1-20 of 41
Miroslaw Markiewicz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treosulfan-Based Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) for Patients with Myelodysplastic Syndrome (MDS): Comparative Analysis of a Randomized Controlled Trial and Real-World Data

Matthias Stelljes, Katja Sockel, Matthias Floeth, Johannes Schetelig, Martin Bornhäuser, Christian Reicherts, Georg Lenz, Thomas Schröder, Rudolf Trenschel, Miroslaw Markiewicz, Hélène Labussière-Wallet, Péter Reményi, Fabio Ciceri, Friedrich Stölzel
Journal: Blood
Blood (2023) 142 (Supplement 1): 3526.
https://doi.org/10.1182/blood-2023-180816
Published: 2023
Journal Articles

Pooled Allogenic Fecal Microbiotherapy MaaT013 for the Treatment of Steroid-Refractory Gastrointestinal Acute Graft-Versus-Host Disease: Results from the Phase IIa Heracles Study and Expanded Access Program

Florent Malard, Michael Loschi, Thomas Cluzeau, Anne Huynh, Sarah Guenounou, Cecile Borel, Faezeh Legrand, Angela Granata, Raynier Devillier, Valerio Maisano, Leonardo Magro, Corentin Orvain, Amandine Charbonnier, Marta Panz-Klapuch, Miroslaw Markiewicz, Deborah Desmier, Niels Moya, Jean-Baptiste Mear, Faustine Lhomme, Caroline Le Jeune, Jérôme Cornillon, Christine Robin, Ernst Holler, Etienne Daguindau, Karin Bilger, Maria Vehreschild, Amandine Le Bourgeois, Patrice Chevallier, Hélène Labussière-Wallet, Delphine Martineau, Marie-Anne Couturier, Claude-Eric Bulabois, Helene Lanic, Vincent Camus, Sylvain Chantepie, Patrice Ceballos, Cyrielle Gasc, Emilie Plantamura, Mohamad Mohty
Journal: Blood
Blood (2021) 138 (Supplement 1): 262.
https://doi.org/10.1182/blood-2021-147709
Published: 2021
Journal Articles

Early Mortality in Patients with Multiple Myeloma Treated with Novel Agents - Analysis from Polish Myeloma Study Group

Grzegorz Charlinski, MDPhD, Agata Tyczyńska, MD, Jan M Zaucha, MD PhD, Adriana Czyz, MD, Jarosław Czyż, MDPhD, Dominik Dytfeld, MDPhD, Bartosz Malecki, MD, Lidia Gil, MDPhD, Szymon Fornagiel, MD, Sebastian Grosicki, MD PhD, Agnieszka Barchnicka, MD, Jadwiga Holojda, MD, Agnieszka Kolkowska, MD PhD, Iwona Hus, MD PhD, Grzegorz Helbig, MDPhD, Anna Kopinska, MD, Anna Masternak, MD, Dariusz Woszczyk, MDPhD, Miroslaw Markiewicz, MDPhD, Jaroslaw Piszcz, MDPhD, Janusz Kloczko, MDPhD, Lidia Usnarska-Zubkiewicz, MDPhD, Tomasz Wrobel, MD PhD, Pawel J. Robak, MDPhD, Tadeusz Robak, MDPhD, Anna Waszczuk-Gajda, MD, Grzegorz Basak, MD PhD, Artur Jurczyszyn, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 36–37.
https://doi.org/10.1182/blood-2020-143003
Published: 2020
Journal Articles

Comparison of a New Reduced Toxicity Myeloablative Treosulfan and Fludarabine Preparative Regimen with Myeloablative Busulfan or Melphalan in Combination with Fludarabine in Older Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes: A Retrospective Matched Pair Analysis of Patients from a Prospective Randomized Trial and the European Blood and Marrow Transplantation Society Registry

Dietrich W. Beelen, Simona Iacobelli, Linda Koster, Dirk-Jan Eikema, Anja van Biezen, Friedrich Stoelzel, MD, Fabio Ciceri, MD, Wolfgang Bethge, Peter Dreger, Eva-Maria Wagner, Péter Reményi, Matthias Stelljes, Miroslaw Markiewicz
Journal: Blood
Blood (2019) 134 (Supplement_1): 3326.
https://doi.org/10.1182/blood-2019-127108
Published: 2019
Journal Articles

Final Results of a Prospective Randomized Multicenter Phase III Trial Comparing Treosulfan/Fludarabine to Reduced Intensity Conditioning with Busulfan/Fludarabine Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Elderly or Comorbid Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome

Dietrich W Beelen, MD PhD, Rudolf Trenschel, MD, Matthias Stelljes, MD, Tamás Masszi, MD Prof., Péter Reményi, Eva-Maria Maria Wagner-Drouet, MD, Peter Dreger, MD Prof., Wolfgang Bethge, MD Prof., Fabio Ciceri, MD, Friedrich Stoelzel, MD, Christian Junghanss, MD, Mauricette Michallet, MD Prof., Miroslaw Markiewicz, MD Prof.
Journal: Blood
Blood (2017) 130 (Supplement 1): 521.
https://doi.org/10.1182/blood.V130.Suppl_1.521.521
Published: 2017
Journal Articles

Allo-HCT from MUD/MRD for Paroxysmal Nocturnal Hemoglobinuria - 12 Years of Experience

Miroslaw Markiewicz, MD, PhD, Prof., Malwina Rybicka-Ramos, MD, Ph. D., Monika Dzierzak-Mietla, MD, PhD, Anna Koclega, MD, PhD, Krzysztof Bialas, MD, Ewa Mendek-Czajkowska, MD, PhD, Slawomira Kyrcz-Krzemien, Prof
Journal: Blood
Blood (2016) 128 (22): 5886.
https://doi.org/10.1182/blood.V128.22.5886.5886
Published: 2016
Journal Articles

No Influence of Post-Transplant Anti-HLA Antibodies on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation from HLA-Mismatched Unrelated Donors

Anna Koclega, MD, PhD, Miroslaw Markiewicz, MD, PhD, Prof., Sylwia Mizia, MSci, Urszula Siekiera, BSci, Alicja Dobrowolska, Monika Dzierzak-Mietla, MD, PhD, Krzysztof Bialas, MD, Slawomira Kyrcz-Krzemien, MD PhD Prof.
Journal: Blood
Blood (2015) 126 (23): 5538.
https://doi.org/10.1182/blood.V126.23.5538.5538
Published: 2015
Journal Articles

Conditioning Intensity Does Not Influence the Outcome of Allogeneic Stem Cell Transplantation in Myelodysplastic Syndrome. a Joint Study By the Polish Adult Leukemia Group and the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation

Lidia Gil, MD PhD, Jadwiga Dwilewicz-Trojaczek, MDPhD, Jan Styczynski, MD PhD, Marek Ussowicz, MDPhD, Krzysztof Kalwak, MD PhD, Ewa Gorczynska, MDPhD, Miroslaw Markiewicz, MD PhD, Monika Dzierzak-Mietla, MD, Patrycja Zielinska, MD PhD, Martyna Borowczyk, Adam Nowicki, MD, Marta Baranska, MD, Mieczyslaw Komarnicki, Maria Bieniaszewska, MD, Andrzej Hellmann, MD PhD, Grzegorz Basak, MD PhD, Wieslaw Wiktor Jedrzejczak, MD, Andrzej Lange, MDPhD, Kazimierz Halaburda, MD, Katarzyna Drabko, MDPhD, Agnieszka Zaucha-Prazmo, Beata Jakubas, MDPhD, Patrycja Mensah-Glanowska, Piotr Rzepecki, PhD MD, Anna Pieczonka, MD, Jacek Wachowiak, MD PhD, Agnieszka Wierzbowska, MD PhD, Jaroslaw Dybko, MD PhD, Tomasz Wrobel, MDPhD, Sebastian Giebel
Journal: Blood
Blood (2014) 124 (21): 2564.
https://doi.org/10.1182/blood.V124.21.2564.2564
Published: 2014
Journal Articles

Favorable Results of Allo-HSCT from MRD in Patients with Myelofibrosis

Miroslaw Markiewicz, MD PhD, Monika Dzierzak-Mietla, MD PhD, Patrycja Zielinska, MD PhD, Agata Wieczorkiewicz-Kabut, MD PhD, Sylwia Mizia, MSci, Mariusz Matyja, MD, Krzysztof Bialas, MD, Grzegorz Helbig, MD PhD Prof., Anna Koclega, MD PhD, Malwina Rybicka, MD, Lech Sedlak, Tomasz Oleksy, Slawomira Kyrcz-Krzemien, MD PhD Prof.
Journal: Blood
Blood (2014) 124 (21): 5934.
https://doi.org/10.1182/blood.V124.21.5934.5934
Published: 2014
Journal Articles

Allo-HSCT from MUD/MRD As a Curative Treatment in Paroxysmal Nocturnal Hemoglobinuria

Miroslaw Markiewicz, MD PhD, Anna Koclega, MD PhD, Monika Dzierzak-Mietla, MD PhD, Patrycja Zielinska, MD PhD, Ewa Mendek-Czajkowska, MD PhD, Krzysztof Bialas, MD, Slawomira Kyrcz-Krzemien, MD PhD Prof.
Journal: Blood
Blood (2014) 124 (21): 1251.
https://doi.org/10.1182/blood.V124.21.1251.1251
Published: 2014
Journal Articles

The Influence Of Anti-HLA Antibodies On Engraftment and Donor’s Chimerism Following Allogeneic Hematopoietic Stem Cell Transplantation From HLA-Mismatched Unrelated Donors

Miroslaw Markiewicz, MD, PhD, Anna Koclega, MD, PhD, Sylwia Mizia, MSci, Urszula Siekiera, PhD, Alicja Dobrowolska, Monika Dzierzak-Mietla, MD, PhD, Patrycja Zielinska, MD, PhD, Krzysztof Bialas, MD, Slawomira Kyrcz-Krzemien, MD
Journal: Blood
Blood (2013) 122 (21): 4542.
https://doi.org/10.1182/blood.V122.21.4542.4542
Published: 2013
Journal Articles

Acceptable Results Of Allo-HSCT From Unrelated Donors In AML Patients Who Failed To Achieve The Complete Remission

Miroslaw Markiewicz, MD, PhD, Monika Dzierzak-Mietla, MD, PhD, Malwina Rybicka, MD, Magdalena Gaj, MD, Anna Koclega, MD, PhD, Patrycja Zielinska, MD, PhD, Krzysztof Bialas, MD, Slawomira Kyrcz-Krzemien, MD
Journal: Blood
Blood (2013) 122 (21): 5520.
https://doi.org/10.1182/blood.V122.21.5520.5520
Published: 2013
Journal Articles

Molecular Screening for Hepatitis B and Hepatitis C Viruses in Allogeneic Hematopoietic Stem Cell Transplantation– a Pilot Study

Malgorzata Sobczyk-Kruszelnicka, Miroslaw Markiewicz, MD, PhD, Agata Wieczorkiewicz-Kabut, MD, Agnieszka Wieclawek, Anna Soja, Monika Dzierzak-Mietla, MD, Anna Koclega, Krzysztof Bialas, Slawomira Kyrcz-Krzemien, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4494.
https://doi.org/10.1182/blood.V120.21.4494.4494
Published: 2012
Journal Articles

Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation From HLA-Mismatched Unrelated Donors

Anna Koclega, Miroslaw Markiewicz, MD, PhD, Urszula Siekiera, PhD, Alicja Dobrowolska, Sylwia Mizia, MSci, Monika Dzierzak-Mietla, MD, Patrycja Zielinska, MD, PhD, Malgorzata Sobczyk-Kruszelnicka, Slawomira Kyrcz-Krzemien, MD PhD Prof
Journal: Blood
Blood (2012) 120 (21): 4475.
https://doi.org/10.1182/blood.V120.21.4475.4475
Published: 2012
Journal Articles

Influence of Minor Histocompatibility Antigens' Disparities On Graft Versus Host Disease and Overall Survival After Allogeneic Hematopoietic Cell Transplantation From Siblings

Monika Dzierzak-Mietla, MD, Miroslaw Markiewicz, MD, PhD, Urszula Siekiera, PhD, Sylwia Mizia, MSci, Agnieszka Karolczyk, Anna Koclega, Patrycja Zielinska, MD, PhD, Malgorzata Sobczyk-Kruszelnicka, Slawomira Kyrcz-Krzemien, MD PhD Prof
Journal: Blood
Blood (2012) 120 (21): 4172.
https://doi.org/10.1182/blood.V120.21.4172.4172
Published: 2012
Journal Articles

The Favorable Results of Allo-HSCT in TKI-Resistant CML,

Miroslaw Markiewicz, MD, PhD, Monika Dzierzak-Mietla, MD, Katarzyna Wisniewska-Piaty, MD, Andrzej Frankiewicz, MD, Anna Koclega, MD, Patrycja Zielinska, MD, PhD, Agata Wieczorkiewicz-Kabut, MD, Malgorzata Sobczyk-Kruszelnicka, MD, Krzysztof Bialas, MD, Slawomira Kyrcz-Krzemien
Journal: Blood
Blood (2011) 118 (21): 4145.
https://doi.org/10.1182/blood.V118.21.4145.4145
Published: 2011
Journal Articles

The Outcome of Allogeneic Stem Cell Transplantation in Chronic Lymphocytic Leukaemia: A Single Centre 10-Year-Experience

Patrycja Zielinska, Malgorzata Krawczyk-Kulis, Miroslaw Markiewicz, Monika Dzierzak-Mietla, Anna Koclega, Robert Liwoch, Anna Kopinska, Slawomira Kyrcz-Krzemien
Journal: Blood
Blood (2011) 118 (21): 4515.
https://doi.org/10.1182/blood.V118.21.4515.4515
Published: 2011
Journal Articles

The Outcome of Autologous Stem Cell Transplantation and the Risk of Relapse in Myeloma and Lymphoma Patients Mobilized Using Plerixafor Compared to Standard Mobilization Regimen

Patrycja Zielinska, Malgorzata Krawczyk-Kulis, Miroslaw Markiewicz, Anna Koclega, Robert Liwoch, Monika Dzierzak-Mietla, Krzysztof Bialas, Slawomira Kyrcz-Krzemien
Journal: Blood
Blood (2011) 118 (21): 4399.
https://doi.org/10.1182/blood.V118.21.4399.4399
Published: 2011
Journal Articles

Donor CTLA-4 Gene Polymorphism Associations with Acute GvHD After Allogeneic Hematopoietic Stem Cell Transplantation

Irena Frydecka, MD, PhD, Lidia Karabon, PhD, Edyta Pawlak-Adamska, PhD, Anna Tomkiewicz, MSc, Tomasz Wrobel, prof., Miroslaw Markiewicz, MD, PhD, Slawomira Kyrcz-Krzemien, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2010.
https://doi.org/10.1182/blood.V118.21.2010.2010
Published: 2011
Journal Articles

ATG Use Is Associated with Frequent Occurrence of Positive Blood Cultures in Patients in the Early Phase After Hematopoietic Stem Cell Transplantation

Marek Seweryn, Urszula Jarosz, Malgorzata Krawczyk-Kulis, Miroslaw Markiewicz, Grzegorz Helbig, Grazyna Bober, Slawomira Kyrcz-Krzemien
Journal: Blood
Blood (2011) 118 (21): 4564.
https://doi.org/10.1182/blood.V118.21.4564.4564
Published: 2011